Manatt Represents A.G.P. in Closings of Stock Offering and Merger of Larkspur Health with ZyVersa

Capital Markets Partners Katherine Blair and Thomas Poletti with support from Associate Danli Lan represented Alliance Global Partners (A.G.P.) with a $10 million convertible preferred stock offering in Larkspur Health Acquisition Corp., a publicly traded special purpose acquisition company (SPAC).

Additionally, Katherine and Thomas concurrently represented A.G.P. as the exclusive financial advisor to Larkspur with the closing of the de-SPAC transaction with ZyVersa, a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop products for patients with renal or inflammatory diseases with high unmet medical needs. The combined company will operate as ZyVersa Therapeutics, Inc. The combined company’s common stock began trading on NASDAQ under ticker symbols “ZVSA”.

Funding from this transaction will allow ZyVersa to take steps to advance their clinical program for VAR 200, a cholesterol efflux mediator for patients with renal disease, and to progress IC 100, an inflammasome ASC inhibitor, to Investigational New Drug Application.

Manatt previously represented A.G.P. with the $75 million initial public offering (IPO) of Larkspur
Read the press release for the business combination here.



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved